Media Center

Vienna, Austria: – High-yield end-to-end bioprocessing specialist CDMO enGenes Biotech will be present at the upcoming BioProcess International (BPI) European conference in Vienna in late April 2026. enGenes Business Development Manager Ophelia Gevaert will represent enGenes at the conference to communicate the CDMO’s distinctive offers, technologies and capabilities in high end production of  recombinant proteins, plasmid DNA, vaccines, antibodies, and peptides. Proprietary

Vienna, Austria – enGenes Biotech will showcase its industry-leading automated and continuous plasmid DNA (pDNA) production capabilities at the annual BioProcess Summit Europe 2026 in Barcelona. The enGenes team, led by CEO Dr. Juergen Mairhofer, will contribute to the Summit’s  Intensified and Continuous Processing  stream with a presentation demonstrating the impact of its iCAP platform on next-generation plasmid DNA manufacturing. iCAP: Unlocking continuous bioprocessing O

Vienna, Austria: – enGenes Biotech GmbH (enGenes) will share details of its progress towards the world’s first platform for truly continuous production of plasmid DNA (pDNA) with the bioscience community at the 44 th International Symposium on the Separation of Proteins, Peptides and Polynucleotides (ISPPP) in Munich. As part of the  Continuous and Intensified Processing  session, enGenes Senior Bioprocess Scientist Dr. Markus Berg will present  “Continuous Downstream Process

Vienna, Austria: – enGenes Biotech GmbH (enGenes) will show its highly advanced bioprocessing solutions in protein expression and vaccine development at Europe’s flagship life sciences partnering conference, BIO-Europe 2025, this year in Vienna. The enGenes team will join other hi-tech biotech companies as part of a combined national presence at the Austrian Pavilion operated by LISAvienna, located at C32 GL in Hall C of the Messe Wien expo center. Enhanced yield expression T

Vienna, Austria: – Bioprocessing solutions expert enGenes Biotech will share insights into its advanced vaccine development capabilities at the upcoming 2025 World Vaccine Congress in Amsterdam. The WVC franchise, with annual congresses in Europe and the USA, has become a leading global knowledge-sharing platform for the whole vaccine R&D and manufacturing value chain. enGenes will be an active participant in the many networking events in Amsterdam, detailing the various ways

Vienna, Austria: – Bioprocessing solutions expert enGenes Biotech is ready to unveil the first working prototype of a fully automated and integrated platform for true continuous production of recombinant proteins and plasmid DNA. The prototype will form the subject of a presentation by its Bioprocess Scientist Florian Simon, detailing the results of his PhD doctoral research resulting from enGenes’ engagement with the ECOnti program. Smart and stable platform Florian’s presen

Vienna, Austria: – Bioprocessing solutions expert enGenes Biotech has been invited to make its first-ever appearance at the Bioprocessing Network conference in Melbourne, Australia. enGenes CEO and co-founder, Dr. Jürgen Mairhofer will be one of the keynote speakers at the conference, presenting the company’s remarkable progress towards the first continuous and sustainable production of proteins in E. coli as part of the ECOnti Project. Continuous production prototype ECOnti,

Vienna, Austria: – Five months after attending the European BioProcess Summit in Barcelona, recombinant proteins and plasmid DNA specialist CDMO enGenes Biotech will also be a high-profile presence at the USA sister event, the 2025 Bioprocessing Summit in Boston. This is the first time enGenes has attended the linked summits on both sides of the Atlantic in a single year, partly reflecting its growing influence on bioprocessing science and technology with its patented express

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will return to the influential Swiss Biotech Day conference in Basel, at the heart of Switzerland’s thriving cluster of life science industries and research. The enGenes team in Basel, led by Head of Business Development, Dr. Karl Hübler, will take part in Swiss Biotech Day’s many networking activities, including one-on-one partnering meetings and its Global Village that hosts delegations f

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech will be a scientific contributor to the third ECI Microbial Engineering Conference (ME III), sharing its latest advances towards continuous production of biotechnological products. Led by Mr. Florian Simon, the enGenes team at ME III will present the latest data from its participation in the ECOnti project that is developing an accelerated, low ecological footprint manufacturing platform for the continuou